Blood test may predict delirium after heart surgery
NCT ID NCT06007755
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to find blood markers that could predict delirium—a state of sudden confusion—after heart surgery. Researchers will measure certain proteins and other substances in the blood of 113 patients before and after surgery. The goal is to develop a simple test to identify high-risk patients and improve prevention.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to identify patients at risk of delirium after heart surgery, allowing earlier prevention.
- What could go wrong
- This is an early exploratory study with only 113 participants. The markers may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 113 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2023
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients aged over 18 years undergoing cardiovascular surgery
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: patients who receive cardiovascular surgery * Patients participated voluntarily and signed informed consent Exclusion Criteria: * past medical history of neurological and psychiatric diseases; severe visual or hearing impairment;
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Delirium are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a quieter, dimmer ICU protect Patients' brains?
- Can a daily supplement shield the brain after delirium?
- Brain surgery delirium: can real-time monitoring protect older patients?
- Could daylight hold the key to preventing delirium?
- Can sensory therapy calm Dementia-Related agitation in hospitals?
- A new care routine aims to shield aging hearts and minds in the ICU